Pulsed Electromagnetic Fields for Multiple Chemical Sensitivity
NCT ID: NCT01834781
Last Updated: 2014-04-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
39 participants
INTERVENTIONAL
2013-04-30
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Pulsed Electromagnetic Field Therapy on Patients With Low Back Pain
NCT03053375
Effect of Pulsed Electromagnetic Stimulation on DOMS
NCT05554874
Impact of Electromagnetic Field Therapy on Pain and Function in Patients With Mechanical Back Pain
NCT06133855
Pulsed Electromagnetic Field (PEMF) Therapy for Post-Concussive Syndrome
NCT02643836
Efficacy of Pulse Electromagnetic Field Therapy (PEMF) in Patients With Subacromial Impingement Syndrome
NCT05057871
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pulsed electromagnetic fields
Pulsed electromagnetic fields is applied transcranially 30 minutes twice a day for 7 days a week over 6 consecutive weeks
Pulsed electromagnetic fields
Wearing the inactive device
The inactive device is worn on the head for 30 minutes twice a day for 7 days a week over 6 consecutive weeks
w/o pulsed electromagnetic fields
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pulsed electromagnetic fields
w/o pulsed electromagnetic fields
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Lifestyle or functional impairments that score ≥ 35 on the Life Impact scale of the Quick Environmental Exposure and Sensitivity Inventory
* Signed informed consent
Exclusion Criteria
* psychosis or a comparable disorder
* epilepsy
* cerebral tumours
* leukaemia or malignancies in the head or neck region
* having a pacemaker or other active implants
* pregnancy or nursing
* unreliable contraception
* drug or alcohol abuse
* a pending application or intentions to apply for early retirement
* initiation of pharmacological treatment which have not steadied
* participation in another research study
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aage Bangs Fond
OTHER
The Danish Research Centre for Chemical Sensitivities
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Danish Research Centre for Chemical Sensitivities
Gentofte Municipality, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tran MT, Skovbjerg S, Arendt-Nielsen L, Christensen KB, Elberling J. Transcranial pulsed electromagnetic fields for multiple chemical sensitivity: study protocol for a randomized, double-blind, placebo-controlled trial. Trials. 2013 Aug 16;14:256. doi: 10.1186/1745-6215-14-256.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MCS-Re5
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.